Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
China
· Delayed Price · Currency is CNY 15.10
+0.17 (1.14%)
Apr 29, 2026, 12:24 PM CST
SHE:300122 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 8,755 | 8,958 | 25,846 | 52,914 | 38,260 | 30,629 | Upgrade
|
| Other Revenue | - | - | 223.28 | 4.08 | 3.85 | 23.46 | Upgrade
|
| Revenue | 8,755 | 8,958 | 26,070 | 52,918 | 38,264 | 30,652 | Upgrade
|
| Revenue Growth (YoY) | -48.52% | -65.64% | -50.73% | 38.30% | 24.83% | 101.79% | Upgrade
|
| Cost of Revenue | 8,179 | 8,256 | 18,971 | 38,986 | 25,518 | 15,728 | Upgrade
|
| Gross Profit | 576.11 | 702.74 | 7,099 | 13,932 | 12,746 | 14,925 | Upgrade
|
| Selling, General & Admin | 2,648 | 2,800 | 3,045 | 3,166 | 2,595 | 2,121 | Upgrade
|
| Research & Development | 916.62 | 932.3 | 971.37 | 968.47 | 854.16 | 552.63 | Upgrade
|
| Other Operating Expenses | -3.89 | -7.9 | 135.45 | 238.75 | 177.02 | 135.23 | Upgrade
|
| Operating Expenses | 3,561 | 3,724 | 4,761 | 4,725 | 4,047 | 3,000 | Upgrade
|
| Operating Income | -2,985 | -3,022 | 2,338 | 9,206 | 8,698 | 11,924 | Upgrade
|
| Interest Expense | - | - | -146.85 | -81 | -53.3 | -56.14 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.01 | 66.63 | 67.94 | 46.09 | 61.47 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 1.67 | 2.28 | 15.4 | -10.1 | Upgrade
|
| Other Non Operating Income (Expenses) | -964.22 | -844.15 | -37.32 | -36.56 | -22.64 | -17.23 | Upgrade
|
| EBT Excluding Unusual Items | -3,949 | -3,866 | 2,222 | 9,159 | 8,684 | 11,902 | Upgrade
|
| Gain (Loss) on Sale of Investments | -14.67 | -14.22 | - | - | - | -5.63 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.47 | 5.88 | 0.05 | 41.37 | 0.01 | 0.04 | Upgrade
|
| Asset Writedown | -13,610 | -13,618 | -0.36 | -0.13 | -0.09 | -1.68 | Upgrade
|
| Other Unusual Items | - | - | 32.05 | 142.34 | 34.31 | 35.83 | Upgrade
|
| Pretax Income | -17,574 | -17,493 | 2,254 | 9,342 | 8,718 | 11,931 | Upgrade
|
| Income Tax Expense | -2,766 | -2,747 | 235.21 | 1,272 | 1,179 | 1,723 | Upgrade
|
| Earnings From Continuing Operations | -14,808 | -14,745 | 2,018 | 8,070 | 7,539 | 10,209 | Upgrade
|
| Minority Interest in Earnings | 23.87 | 22.11 | - | - | - | - | Upgrade
|
| Net Income | -14,785 | -14,723 | 2,018 | 8,070 | 7,539 | 10,209 | Upgrade
|
| Net Income to Common | -14,785 | -14,723 | 2,018 | 8,070 | 7,539 | 10,209 | Upgrade
|
| Net Income Growth | - | - | -74.99% | 7.04% | -26.15% | 209.23% | Upgrade
|
| Shares Outstanding (Basic) | 2,394 | 2,394 | 2,395 | 2,400 | 2,400 | 2,400 | Upgrade
|
| Shares Outstanding (Diluted) | 2,394 | 2,394 | 2,395 | 2,400 | 2,400 | 2,400 | Upgrade
|
| Shares Change (YoY) | -0.05% | -0.06% | -0.20% | - | - | -0.00% | Upgrade
|
| EPS (Basic) | -6.18 | -6.15 | 0.84 | 3.36 | 3.14 | 4.25 | Upgrade
|
| EPS (Diluted) | -6.18 | -6.15 | 0.84 | 3.36 | 3.14 | 4.25 | Upgrade
|
| EPS Growth | - | - | -74.94% | 7.04% | -26.15% | 209.23% | Upgrade
|
| Free Cash Flow | 4,600 | 4,548 | -5,344 | 7,862 | 535.93 | 6,575 | Upgrade
|
| Free Cash Flow Per Share | 1.92 | 1.90 | -2.23 | 3.28 | 0.22 | 2.74 | Upgrade
|
| Dividend Per Share | - | - | 0.200 | 0.800 | 0.333 | 0.400 | Upgrade
|
| Dividend Growth | - | - | -75.00% | 140.02% | -16.68% | 20.01% | Upgrade
|
| Gross Margin | 6.58% | 7.84% | 27.23% | 26.33% | 33.31% | 48.69% | Upgrade
|
| Operating Margin | -34.09% | -33.73% | 8.97% | 17.40% | 22.73% | 38.90% | Upgrade
|
| Profit Margin | -168.87% | -164.35% | 7.74% | 15.25% | 19.70% | 33.30% | Upgrade
|
| Free Cash Flow Margin | 52.54% | 50.77% | -20.50% | 14.86% | 1.40% | 21.45% | Upgrade
|
| EBITDA | -2,450 | -2,520 | 2,710 | 9,518 | 9,003 | 12,297 | Upgrade
|
| EBITDA Margin | -27.98% | -28.13% | 10.40% | 17.99% | 23.53% | 40.12% | Upgrade
|
| D&A For EBITDA | 534.58 | 502.12 | 372.28 | 311.85 | 304.88 | 372.24 | Upgrade
|
| EBIT | -2,985 | -3,022 | 2,338 | 9,206 | 8,698 | 11,924 | Upgrade
|
| EBIT Margin | -34.09% | -33.73% | 8.97% | 17.40% | 22.73% | 38.90% | Upgrade
|
| Effective Tax Rate | - | - | 10.44% | 13.62% | 13.52% | 14.44% | Upgrade
|
| Revenue as Reported | - | - | 26,070 | 52,918 | 38,264 | 30,652 | Upgrade
|
| Advertising Expenses | - | - | 395.29 | 475.81 | 395.05 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.